Breaking News, Collaborations & Alliances

Vistin Pharma Purchases 15% Stake in CF Pharma

Signals potential for a closer partnership in the future.

Vistin Pharma has acquired a 15% share in CF Pharma Kft, an API CDMO located in Budapest, Hungary with a broad customer base of international pharmaceutical companies.
 
CF Pharma has a proven track record in developing and commercializing Active Pharmaceutical Ingredients (APIs). It currently has five commercial APIs on the market, with another eight APIs under development.
 
The transaction price consists of a base price and an earn-out- element, with an agreed cap of €1.6 million.
 
“I am very pleased to announce that Vistin Pharma now has acquired a minority stake in CF Pharma. We see this as a first agreed step in a potential closer partnership in the future, which can broaden our product portfolio and form an important basis for future growth. The cooperation with CF Pharma is a first move in order for Vistin Pharma to execute on the strategy to become a multi-product European API Contract Development and Manufacturing Organization (API CDMO),” says Magnus Tolleshaug, CEO of Vistin Pharma.

Other Industry Acquisitions

Don’t miss Contract Pharma’s 2024 Pharmaceutical Industry Mergers & Acquisitions Roundup.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters